Fischer Medical Ventures Limited has announced a significant international development through its wholly owned subsidiary, Time Medical International Ventures (India) Private Limited. The company has partnered with PT Pharmindo Rimpang Kokoh (PT Pariko) in Indonesia to support the country’s tuberculosis eradication programme with advanced, AI-driven portable X-ray systems.
This partnership marks an important step in strengthening global healthcare infrastructure, especially in regions where early detection and rapid screening remain critical. The pilot phase involves the deployment of 250 portable, AI-enabled X-ray units across Indonesia by March 2026. With this initiative, Fischer Medical Ventures positions itself as a strategic technology partner in Indonesia’s public health initiatives focused on combating TB.
The agreement, valued at approximately USD 6.5 million, will be executed in multiple tranches. Although the collaboration is being implemented within the private sector, it is aligned with Indonesia’s broader healthcare goals aimed at improving diagnostic accessibility and accelerating disease detection in remote and underserved areas.
Time Medical International Ventures (India) Private Limited will be responsible for delivering the portable imaging systems, ensuring efficient rollout and technological support throughout the pilot phase. The integration of AI-based diagnostics is expected to enhance screening accuracy, speed, and field-level usability, making the solution particularly suitable for mobile healthcare campaigns.
